Zdrowie i gospodarka · 19/05/2016

FDA Renews Blood Products Advisory Committee for 2 Additional Years

The Food and Drug Administration (FDA) is renewing the Blood Products Advisory Committee for an additional 2 years, with the new charter set to expire on May 13, 2018, following a determination by the Commissioner of Food and Drugs that it is in the public interest to do so.